DrugPatentWatch Database Preview
Biologic Patents Expiring in 2031
Biologic Patents With Estimated Expirations in 2031
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | The Board of Trustees of the University of Illinois (Urbana, IL) The Board of Regents of the University of Texas System (Austin, TX) | 2031-10-14 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | 2031-04-05 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | The Ohio State University (Columbus, OH) Immunomedics, Inc. (Morris Plains, NJ) | 2031-07-18 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Calithera Biosciences Inc. (South San Francisco, CA) | 2031-11-21 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Board of Regents of the University of Texas (Austin, TX) | 2031-03-30 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (Gainesville, FL) | 2031-04-01 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Baker Hughes Incorporated (Houston, TX) | 2031-05-13 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
